SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case

Lupus. 2021 Sep;30(10):1698-1699. doi: 10.1177/09612033211027940. Epub 2021 Jul 1.

Authors

Fulvia Ceccarelli¹, Giulio Olivieri¹, Francesco Natalucci¹, Cristiano Alessandri¹, Fabrizio Conti¹

Affiliation

¹ Lupus Clinic, Reumatologia, Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, Roma, Italy.

PMID: 34192958
DOI: 10.1177/09612033211027940

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
B-Lymphocytes / drug effects
BNT162 Vaccine
COVID-19 / immunology*
COVID-19 / prevention & control
COVID-19 Vaccines / immunology*
Drug Administration Schedule
Female
Humans
Lupus Erythematosus, Systemic / drug therapy*
Lymphocyte Depletion
Rituximab / administration & dosage
Rituximab / adverse effects*
SARS-CoV-2

Substances

COVID-19 Vaccines
Rituximab
BNT162 Vaccine